These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

410 related articles for article (PubMed ID: 31774113)

  • 21. Recent Development in Omics Studies.
    Aizat WM; Ismail I; Noor NM
    Adv Exp Med Biol; 2018; 1102():1-9. PubMed ID: 30382565
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Computational polypharmacology with text mining and ontologies.
    Plake C; Schroeder M
    Curr Pharm Biotechnol; 2011 Mar; 12(3):449-57. PubMed ID: 21133848
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Impact of ∼omics in the detection and validation of potential anti-infective drugs.
    Maldonado-Carmona N; Vázquez-Hernández M; Patiño Chávez OJ; Rodríguez-Luna SD; Jiménez Rodríguez O; Sanchez S; Ceapă CD
    Curr Opin Pharmacol; 2019 Oct; 48():1-7. PubMed ID: 30921690
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Chemical proteomics and discovery of drug targets].
    Yang HQ; Li XJ
    Yao Xue Xue Bao; 2011 Aug; 46(8):877-82. PubMed ID: 22007509
    [TBL] [Abstract][Full Text] [Related]  

  • 25. IPAD: the Integrated Pathway Analysis Database for Systematic Enrichment Analysis.
    Zhang F; Drabier R
    BMC Bioinformatics; 2012; 13 Suppl 15(Suppl 15):S7. PubMed ID: 23046449
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Drug Repositioning for Alzheimer's Disease Based on Systematic 'omics' Data Mining.
    Zhang M; Schmitt-Ulms G; Sato C; Xi Z; Zhang Y; Zhou Y; St George-Hyslop P; Rogaeva E
    PLoS One; 2016; 11(12):e0168812. PubMed ID: 28005991
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Chemical genomics and emerging DNA technologies in the identification of drug mechanisms and drug targets.
    Olsen LC; Færgeman NJ
    Curr Top Med Chem; 2012; 12(12):1331-45. PubMed ID: 22690680
    [TBL] [Abstract][Full Text] [Related]  

  • 28. "Omics" in pharmaceutical research: overview, applications, challenges, and future perspectives.
    Yan SK; Liu RH; Jin HZ; Liu XR; Ye J; Shan L; Zhang WD
    Chin J Nat Med; 2015 Jan; 13(1):3-21. PubMed ID: 25660284
    [TBL] [Abstract][Full Text] [Related]  

  • 29. OmixLitMiner: A Bioinformatics Tool for Prioritizing Biological Leads from 'Omics Data Using Literature Retrieval and Data Mining.
    Steffen P; Wu J; Hariharan S; Voss H; Raghunath V; Molloy MP; Schlüter H
    Int J Mol Sci; 2020 Feb; 21(4):. PubMed ID: 32092871
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Challenges and opportunities for oncology biomarker discovery.
    Deyati A; Younesi E; Hofmann-Apitius M; Novac N
    Drug Discov Today; 2013 Jul; 18(13-14):614-24. PubMed ID: 23280501
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Modern bioinformatics meets traditional Chinese medicine.
    Gu P; Chen H
    Brief Bioinform; 2014 Nov; 15(6):984-1003. PubMed ID: 24067932
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Network-Based Approaches for Multi-omics Integration.
    Zhou G; Li S; Xia J
    Methods Mol Biol; 2020; 2104():469-487. PubMed ID: 31953831
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Towards quantitative biology: integration of biological information to elucidate disease pathways and to guide drug discovery.
    Fischer HP
    Biotechnol Annu Rev; 2005; 11():1-68. PubMed ID: 16216773
    [TBL] [Abstract][Full Text] [Related]  

  • 34. OMICs Technologies for Natural Compounds-based Drug Development.
    Aborode AT; Awuah WA; Mikhailova T; Abdul-Rahman T; Pavlock S; Kundu M; Yarlagadda R; Pustake M; Correia IFDS; Mehmood Q; Shah P; Mehta A; Ahmad S; Asekun A; Nansubuga EP; Amaka SO; Shkodina AD; Alexiou A
    Curr Top Med Chem; 2022 Oct; 22(21):1751-1765. PubMed ID: 35894473
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Integration of target discovery, drug discovery and drug delivery: A review on computational strategies.
    Duarte Y; Márquez-Miranda V; Miossec MJ; González-Nilo F
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2019 Jul; 11(4):e1554. PubMed ID: 30932351
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Contributions from emerging transcriptomics technologies and computational strategies for drug discovery.
    Kadioglu O; Efferth T
    Invest New Drugs; 2014 Dec; 32(6):1316-9. PubMed ID: 24633650
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Large-scale integrated databases supporting drug discovery.
    Roter AH
    Curr Opin Drug Discov Devel; 2005 May; 8(3):309-15. PubMed ID: 15892245
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Report: NIA workshop on translating genetic variants associated with longevity into drug targets.
    Schork NJ; Raghavachari N;
    Geroscience; 2018 Dec; 40(5-6):523-538. PubMed ID: 30374935
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Using bioinformatics for drug target identification from the genome.
    Jiang Z; Zhou Y
    Am J Pharmacogenomics; 2005; 5(6):387-96. PubMed ID: 16336003
    [TBL] [Abstract][Full Text] [Related]  

  • 40. targetTB: a target identification pipeline for Mycobacterium tuberculosis through an interactome, reactome and genome-scale structural analysis.
    Raman K; Yeturu K; Chandra N
    BMC Syst Biol; 2008 Dec; 2():109. PubMed ID: 19099550
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.